These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 37079138

  • 1. 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas.
    Noltes ME, Rotstein L, Eskander A, Kluijfhout WP, Bongers P, Brouwers AH, Kruijff S, Metser U, Pasternak JD, Veit-Haibach P.
    Langenbecks Arch Surg; 2023 Apr 20; 408(1):155. PubMed ID: 37079138
    [Abstract] [Full Text] [Related]

  • 2. A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies.
    Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, Lefèvre M, Tassart M, Montravers F, Périé S, Talbot JN.
    Medicine (Baltimore); 2015 Oct 20; 94(41):e1701. PubMed ID: 26469908
    [Abstract] [Full Text] [Related]

  • 3. Preoperative F-18 fluorocholine PET/CT for the detection of hyperfunctioning parathyroid glands in patients with secondary or tertiary hyperparathyroidism: comparison with Tc-99m sestamibi scan and neck ultrasound.
    Chen YH, Chen HT, Lee MC, Liu SH, Wang LY, Lue KH, Chan SC.
    Ann Nucl Med; 2020 Aug 20; 34(8):527-537. PubMed ID: 32436180
    [Abstract] [Full Text] [Related]

  • 4. Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism?
    Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, Kerrou K, Balogova S, Talbot JN, Périé S.
    J Clin Endocrinol Metab; 2014 Dec 20; 99(12):4531-6. PubMed ID: 25215560
    [Abstract] [Full Text] [Related]

  • 5. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
    Kluijfhout WP, Vorselaars WM, Vriens MR, Borel Rinkes IH, Valk GD, de Keizer B.
    Eur J Radiol; 2015 Sep 20; 84(9):1745-51. PubMed ID: 26047823
    [Abstract] [Full Text] [Related]

  • 6. 18F-Fluorocholine PET/CT Is More Sensitive Than 11C-Methionine PET/CT for the Localization of Hyperfunctioning Parathyroid Tissue in Primary Hyperparathyroidism.
    Mathey C, Keyzer C, Blocklet D, Van Simaeys G, Trotta N, Lacroix S, Corvilain B, Goldman S, Moreno-Reyes R.
    J Nucl Med; 2022 May 20; 63(5):785-791. PubMed ID: 34413141
    [Abstract] [Full Text] [Related]

  • 7. Performance of F-18 Fluorocholine PET/CT for Detection of Hyperfunctioning Parathyroid Tissue in Patients with Elevated Parathyroid Hormone Levels and Negative or Discrepant Results in conventional Imaging.
    Uslu-Beşli L, Sonmezoglu K, Teksoz S, Akgun E, Karayel E, Pehlivanoglu H, Khosroshahi BR, Ocak M, Kabasakal L, Sager S, Bukey Y.
    Korean J Radiol; 2020 Feb 20; 21(2):236-247. PubMed ID: 31997599
    [Abstract] [Full Text] [Related]

  • 8. Assessment and Comparison of 18F-Fluorocholine PET and 99mTc-Sestamibi Scans in Identifying Parathyroid Adenomas: A Metaanalysis.
    Whitman J, Allen IE, Bergsland EK, Suh I, Hope TA.
    J Nucl Med; 2021 Sep 01; 62(9):1285-1291. PubMed ID: 33452040
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic Performance of Cervical Ultrasound, 99mTc-Sestamibi Scintigraphy, and Contrast-Enhanced 18F-Fluorocholine PET in Primary Hyperparathyroidism.
    Boudousq V, Guignard N, Gilly O, Chambert B, Mamou A, Moranne O, Zemmour M, Sharara H, Lallemant B.
    J Nucl Med; 2022 Jul 01; 63(7):1081-1086. PubMed ID: 34857659
    [Abstract] [Full Text] [Related]

  • 11. Comparative Effectiveness of Ultrasonography, 99mTc-Sestamibi, and 18F-Fluorocholine PET/CT in Detecting Parathyroid Adenomas in Patients With Primary Hyperparathyroidism.
    Thanseer N, Bhadada SK, Sood A, Mittal BR, Behera A, Gorla AKR, Kalathoorakathu RR, Singh P, Dahiya D, Saikia UN, Rao SD.
    Clin Nucl Med; 2017 Dec 01; 42(12):e491-e497. PubMed ID: 28902729
    [Abstract] [Full Text] [Related]

  • 12. 18F-fluorocholine PET/CT and conventional imaging in primary hyperparathyroidism.
    Dudoignon D, Delbot T, Cottereau AS, Dechmi A, Bienvenu M, Koumakis E, Cormier C, Gaujoux S, Groussin L, Cochand-Priollet B, Clerc J, Wartski M.
    Diagn Interv Imaging; 2022 May 01; 103(5):258-265. PubMed ID: 35039246
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism.
    Bossert I, Chytiris S, Hodolic M, Croce L, Mansi L, Chiovato L, Mariani G, Trifirò G.
    J Endocrinol Invest; 2019 Apr 01; 42(4):419-426. PubMed ID: 30094743
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 18F-Fluorocholine PET/CT and Parathyroid 4D Computed Tomography for Primary Hyperparathyroidism: The Challenge of Reoperative Patients.
    Amadou C, Bera G, Ezziane M, Chami L, Delbot T, Rouxel A, Leban M, Herve G, Menegaux F, Leenhardt L, Kas A, Trésallet C, Ghander C, Lussey-Lepoutre C.
    World J Surg; 2019 May 01; 43(5):1232-1242. PubMed ID: 30659347
    [Abstract] [Full Text] [Related]

  • 17. Superior sensitivity of 18F-fluorocholine: PET localization in primary hyperparathyroidism.
    Graves CE, Hope TA, Kim J, Pampaloni MH, Kluijfhout W, Seib CD, Gosnell JE, Shen WT, Roman SA, Sosa JA, Duh QY, Suh I.
    Surgery; 2022 Jan 01; 171(1):47-54. PubMed ID: 34301418
    [Abstract] [Full Text] [Related]

  • 18. Retrospective real-life study on preoperative imaging for minimally invasive parathyroidectomy in primary hyperparathyroidism.
    Bijnens J, Van den Bruel A, Vander Poorten V, Goethals I, Van Schandevyl S, Dick C, De Geeter F.
    Sci Rep; 2022 Oct 19; 12(1):17427. PubMed ID: 36261462
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.